Dan Gusenleitner
Director, Computational Biology
,
Bayer
I am passionate about leveraging data and cutting-edge technologies to improve cancer drug development and advance personalized medicine—matching the right patients with the right treatments. Throughout my career, I've collaborated with clinical teams to champion data-driven decision-making.
My personal experiences with cancer drive my commitment to developing knowledge systems that integrate clinical, imaging, and biomarker data. These systems provide real-time access to high-quality information, enhancing our ability to make timely, informed decisions. I believe that by harnessing comprehensive cancer data, we can deepen our understanding of cancer biology and drug mechanisms while minimizing potential side effects.
Ultimately, curing cancer is a team effort requiring diverse expertise and leadership founded not just on vision, but on empathy that recognizes the human behind each patient.
My personal experiences with cancer drive my commitment to developing knowledge systems that integrate clinical, imaging, and biomarker data. These systems provide real-time access to high-quality information, enhancing our ability to make timely, informed decisions. I believe that by harnessing comprehensive cancer data, we can deepen our understanding of cancer biology and drug mechanisms while minimizing potential side effects.
Ultimately, curing cancer is a team effort requiring diverse expertise and leadership founded not just on vision, but on empathy that recognizes the human behind each patient.
Sessions
-
Bayer’s R&D Data Science Ecosystem – A Central Nervous System to Improve Efficiency and Success Rates in Pharma04-Jun-2026Biopharma Data Management Stage